Dr. Elrafei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Eastchester Road
Bronx, NY 10469Phone+1 718-732-4000Fax+1 718-828-1960
Summary
- Dr. Tarek Elrafei is an oncologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi and Montefiore Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 22 years. He specializes in breast cancer, cancer genetics/cancer risk assessment, and hematologic oncology and is experienced in hematologic oncology, hematology, and medical oncology.
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2000 - 2003
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1996 - 1999
- Nova Southeastern University College of Osteopathic MedicineClass of 1995
- Rutgers UniversityB.S., 1987 - 1991
Certifications & Licensure
- NY State License 1998 - 2026
- NJ State License 2000 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 65 citations36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature.Marianna Strakhan, Nahun Galeas, Kamila Bakirhan, Karenza Alexis, Tarek N. Elrafei
Case Reports in Hematology. 2014-10-15 - 1 citationsA systematic review of the literature on localized gastrointestinal tract amyloidosis: Presentation, management and outcomes.Mariuxi Alexandra Viteri Malone, David Alfonso Alejos Castillo, Heitor Tavares Santos, Anahat Kaur, Tarek Elrafei
European Journal of Haematology. 2024-10-01 - 28 citationsA Multidisciplinary Patient Navigation Program Improves Compliance With Adjuvant Breast Cancer Therapy in a Public Hospital.Maria Castaldi, Saman Safadjou, Tarek N. Elrafei, John McNelis
American Journal of Medical Quality. 2017-07-01
Journal Articles
- Using a Patient Navigation Program to Overcome Health Care Disparities in Cancer Treatment in a Multicultural SettingTarek Elrafei, Maria Castaldi, Marianna Strakhan, Karenza Alexis, Louis Juden Reed, Bassam Shaker, Tina Stanise, Mariaelena Marquez, Richard J. Gralla, Supportive Care in Cancer, International MASCC/ISOO Symposium, 6/27/2013
- A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients with oxaplatin-refra...Allyson J. Ocean, Tanios S. Bekaii-Saab, Imran Chaudhary, Romae Palmer, Paul J. Christos, Alice Mercado, Erika O. Florendo, Veronica A. Rosales, Joseph T. Ruggiero, El..., Journal of Clinical Oncology, 1/1/2012
- Dermatofibrosarcoma protuberans-derived fibrosarcoma: Response to escalated dose imatinib mesylate (IM) and second generation kinase-inhibitor nilotinibT.N. Elrafei, G Chrysofakis, N Simmons, L.J. Reed, Journal of Clinical Oncology, 5/1/2011
- Join now to see all
Abstracts/Posters
- Can patient navigation help overcome barriers to breast cancer treatment in patients with health care disparities?Tarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Richard J. Gralla, Mariaelena Marquez, William Bodner, Louis Juden Reed, Marianna Strakhan, Karenza M. A..., San Antonio Breast Cancer Symposium, San Antonio, TX, 12/11/2013
- Overcoming health care disparities in cancer treatment by instituting a patient navigation programTarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Mariaelena Marquez, William Bodner, Louis Juden Reed, Karenza M. Alexis, Marianna Strakhan, Richard J. G..., Journal of Clinical Oncology, 1/31/2013
- Dermatofibrosarcoma protuberans: Preoperative therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical responseM. Macapinlac, T. Elrafei, I. Cunningham, M. Horowitz, F. Paracha, R. Mbaoma, D. Jayabalan, S. Mani, Proceedings of American Society of Clinical Oncology, 6/1/2004
- Join now to see all
External Links
- NYCBShttps://nycancer.com/doctors/dr_tarek_elrafei
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: